Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Value of testosterone in saliva in the diagnosis of Alzheimer's disease

de la Rubia Ortí JE, García-Pardo MP, Rochina MJ.

Med Clin (Barc). 2019 Jan 18;152(2):75-76. doi: 10.1016/j.medcli.2018.03.006. Epub 2018 Apr 25.

APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis

Uddin MS, Kabir MT, Al Mamun A, Abdel-Daim MM, Barreto GE, Ashraf GM.

Mol Neurobiol. 2019 Apr;56(4):2450-2465. doi: 10.1007/s12035-018-1237-z. Epub 2018 Jul 21.

DAPK1: a Novel Pathology and Treatment Target for Alzheimer's Disease

Xu LZ, Li BQ, Jia JP.

Mol Neurobiol. 2019 Apr;56(4):2838-2844. doi: 10.1007/s12035-018-1242-2. Epub 2018 Jul 31.

Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study

Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V; MAPT/DSA study group.

Br J Clin Pharmacol. 2019 Jan;85(1):71-99. doi: 10.1111/bcp.13734. Epub 2018 Oct 17.

Energy and Protein Intake of Alzheimer's Disease Patients Compared to Cognitively Normal Controls: Systematic Review

Doorduijn AS, van de Rest O, van der Flier WM, Visser M, de van der Schueren MAE.

J Am Med Dir Assoc. 2019 Jan;20(1):14-21. doi: 10.1016/j.jamda.2018.06.019. Epub 2018 Aug 9.

Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?

Merlo S, Spampinato SF, Sortino MA.

CNS Neurosci Ther. 2019 Jan;25(1):5-13. doi: 10.1111/cns.13050. Epub 2018 Aug 12.

Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline

Chornenkyy Y, Wang WX, Wei A, Nelson PT.

Brain Pathol. 2019 Jan;29(1):3-17. doi: 10.1111/bpa.12655. Epub 2018 Oct 9.

Definition of Late Onset Alzheimer's Disease and Anticipation Effect of Genome-Wide Significant Risk Variants: Pilot Study of the APOE e4 Allele

De Luca V, Spalletta G, Souza RP, Graff A, Bastos-Rodrigues L, Camargos Bicalho MA.

Neuropsychobiology. 2019;77(1):8-12. doi: 10.1159/000490739. Epub 2018 Aug 15.

Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis

Chan VTT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC, Wong TY, Chen C, Ikram MK, Whitson HE, Lad EM, Mok VCT, Cheung CY.

Ophthalmology. 2019 Apr;126(4):497-510. doi: 10.1016/j.ophtha.2018.08.009. Epub 2018 Aug 13.

Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment

Chandra A, Dervenoulas G, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

J Neurol. 2019 Jun;266(6):1293-1302. doi: 10.1007/s00415-018-9016-3. Epub 2018 Aug 17.

Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors

Takeda S.

Neurosci Res. 2019 Apr;141:36-42. doi: 10.1016/j.neures.2018.08.005. Epub 2018 Aug 16.

Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer's disease: A narrative review

Isik AT, Soysal P, Solmi M, Veronese N.

Int J Geriatr Psychiatry. 2019 Sep;34(9):1326-1334. doi: 10.1002/gps.4965. Epub 2018 Sep 10.

Scan-Time Corrections for 80-100-min Standardizetd Uptake Volume Ratios to Measure the (18)F-AV-1451 Tracer for Tau Imaging

He M, Baker SL, Shah VD, Lockhart SN, Jagust WJ.

IEEE Trans Med Imaging. 2019 Mar;38(3):697-709. doi: 10.1109/TMI.2018.2870441. Epub 2018 Sep 17.

Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology

Costa C, Romoli M, Liguori C, Farotti L, Eusebi P, Bedetti C, Siliquini S, Cesarini EN, Romigi A, Mercuri NB, Parnetti L, Calabresi P.

Neurobiol Aging. 2019 Jan;73:61-67. doi: 10.1016/j.neurobiolaging.2018.09.006. Epub 2018 Sep 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias